Whooping cough

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1489A37.0A37.1A37.8
Who is this for?
Show terms as
11Active trials59Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Whooping cough, also known as pertussis, is an acute, highly contagious respiratory infection caused by the bacterium Bordetella pertussis (ICD-10: A37.0). It can also be caused by Bordetella parapertussis (A37.1) or other Bordetella species (A37.8). The disease primarily affects the respiratory system, specifically the upper and lower airways, and is characterized by severe, prolonged coughing episodes. It is transmitted via respiratory droplets and is particularly dangerous in infants and young children, though it can affect individuals of any age. The clinical course of whooping cough typically progresses through three stages. The catarrhal stage (1–2 weeks) resembles a common cold with mild cough, runny nose, and low-grade fever. This is followed by the paroxysmal stage (1–6 weeks or longer), marked by intense, repetitive coughing fits (paroxysms) often followed by a characteristic high-pitched inspiratory "whoop," post-tussive vomiting, and exhaustion. Infants may present with apnea (pauses in breathing) and cyanosis rather than the classic whoop. The convalescent stage involves gradual recovery over weeks to months. Complications can include pneumonia, seizures, encephalopathy, rib fractures from severe coughing, and death, particularly in unvaccinated infants. Treatment includes macrolide antibiotics (such as azithromycin, erythromycin, or clarithromycin), which are most effective when administered early in the disease course and help reduce transmission. Supportive care, including hydration, oxygen supplementation, and hospitalization for severe cases (especially in infants), is essential. Prevention through vaccination remains the cornerstone of disease control, with DTaP (diphtheria-tetanus-acellular pertussis) vaccine recommended for children and Tdap booster for adolescents, adults, and pregnant women. Despite widespread vaccination programs, pertussis remains endemic worldwide with periodic outbreaks.

Also known as:

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Nov 2025Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis

Dalhousie University — PHASE1

TrialRECRUITING
May 202510-year Follow-up After a Single Dose Acellular Pertussis Vaccination

Mahidol University — PHASE4

TrialRECRUITING
Feb 2025Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults

BioNet-Asia Co., Ltd. — PHASE3

TrialACTIVE NOT RECRUITING
Dec 2024Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women

BioNet-Asia Co., Ltd.

TrialACTIVE NOT RECRUITING
Oct 2024A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human Infection

Dimitri Diavatopoulos — PHASE4

TrialRECRUITING
Dec 2023Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

Hospital Clinico Universitario de Santiago

TrialRECRUITING
Nov 2023Impact of Bacterial Expression and Immune Response in the Severity of Pertussis

Institut Pasteur — NA

TrialRECRUITING
Dec 2022Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks

University of Southampton — NA

TrialRECRUITING
Mar 2022Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women

Farzanah Laher — PHASE4

TrialACTIVE NOT RECRUITING
Jul 2021The Optimal Timing of Vaccination in Pregnancy

Elke Leuridan, MD, PhD

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Whooping cough.

11 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

11 recruitingView all trials with filters →
Phase 31 trial
Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults
Phase 3
Active
· Sites: Bangkok, Bangkok; Bangkok, Bangkok +1 more · Age: 1875 yrs
Phase 43 trials
A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human Infection
Phase 4
Actively Recruiting
· Sites: Nijmegen · Age: 1850 yrs
Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women
Phase 4
Active
· Sites: Johannesburg, GP · Age: 1839 yrs
10-year Follow-up After a Single Dose Acellular Pertussis Vaccination
Phase 4
Actively Recruiting
PI: Punnee Pitisuttithum (Vaccine trial Centre) · Sites: Bangkok Noi, Bangkok Metropolis; Ratchathewi, Bangkok Metropolis
Phase 11 trial
Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
Phase 1
Actively Recruiting
· Sites: Halifax, Nova Scotia · Age: 1850 yrs
N/A2 trials
Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
N/A
Actively Recruiting
· Sites: Southampton, Hampshire · Age: 1855 yrs
Impact of Bacterial Expression and Immune Response in the Severity of Pertussis
N/A
Actively Recruiting
PI: Julie Toubiana, MD (Institut Pasteur) · Sites: Bordeaux; Colombes +12 more · Age: 015 yrs
Other4 trials
The Optimal Timing of Vaccination in Pregnancy
Actively Recruiting
· Sites: Edegem, Antwerp · Age: 1899 yrs
Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women
Active
PI: Soaud Mansouri, PhD. (Bionet-Asia Co., Ltd (Branch1)) · Sites: Bangkok, Bangkok
Pediatric Pertussis in Ambulatory Settings
Actively Recruiting
PI: Nicole Guiso (Institut Pasteur) · Sites: Créteil · Age: 018 yrs
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
Actively Recruiting
· Sites: Santiago de Compostela, A Coruña · Age: 1899 yrs

Specialists

Showing 25 of 59View all specialists →
NC
Nicholas Carbonetti
Specialist
1 Whooping cough publication
MD
Michael D Decker
Specialist
1 Whooping cough publication
KE
Kathryn M Edwards
Specialist
1 Whooping cough publication
SN
Shobhana Nagraj
Specialist
1 Whooping cough publication
MR
Mohammad S Razai
Specialist
1 Whooping cough publication
FM
Federico Martinón-Torres
Specialist
1 Whooping cough publication
PO
Pippa Oakeshott
Specialist
1 Whooping cough publication
FG
Francisco-Javier González-Barcala
Specialist
1 Whooping cough publication
MR
Maggie Rae
Specialist
1 Whooping cough publication
JH
John C Hagan
Specialist
1 Whooping cough publication
DM
Dominic Mellon
Specialist
1 Whooping cough publication
KR
Karen Roush
SYOSSET, NY
Specialist
1 Whooping cough publication
FV
Felipe Villar-Álvarez
Specialist
1 Whooping cough publication
ES
Elizabeth Smout
Specialist
1 Whooping cough publication
SB
Sima Berendes
Specialist
1 Whooping cough publication
TP
Thanh Nguyen, PhD
Specialist
PI on 1 active trial
JP
Jose M Ramirez, MD; PhD
Specialist
PI on 1 active trial
DM
Daniel Salmon, PhD, MPH
HENDERSON, TN
Specialist
PI on 1 active trial
RP
Robert Bednarczyk, PhD
Specialist
PI on 1 active trial
AH
Anthony R Harnden
Specialist
PI on 1 active trial
SM
Soaud Mansouri
Specialist
PI on 1 active trial
SO
Saad B Omer
Specialist
PI on 1 active trial
PH
Paul T Heath
Specialist
PI on 1 active trial
TT
Thomas R. Talbot
Specialist
PI on 1 active trial
JT
Julie Toubiana
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Whooping cough.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Whooping coughForum →

No community posts yet. Be the first to share your experience with Whooping cough.

Start the conversation →

Latest news about Whooping cough

Disease timeline:

New recruiting trial: Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks

A new clinical trial is recruiting patients for Whooping cough

New recruiting trial: Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis

A new clinical trial is recruiting patients for Whooping cough

New recruiting trial: Pediatric Pertussis in Ambulatory Settings

A new clinical trial is recruiting patients for Whooping cough

New recruiting trial: A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human Infection

A new clinical trial is recruiting patients for Whooping cough

New recruiting trial: Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

A new clinical trial is recruiting patients for Whooping cough

New recruiting trial: 10-year Follow-up After a Single Dose Acellular Pertussis Vaccination

A new clinical trial is recruiting patients for Whooping cough

New recruiting trial: Impact of Bacterial Expression and Immune Response in the Severity of Pertussis

A new clinical trial is recruiting patients for Whooping cough

New recruiting trial: The Optimal Timing of Vaccination in Pregnancy

A new clinical trial is recruiting patients for Whooping cough

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Whooping cough

What is Whooping cough?

Whooping cough, also known as pertussis, is an acute, highly contagious respiratory infection caused by the bacterium Bordetella pertussis (ICD-10: A37.0). It can also be caused by Bordetella parapertussis (A37.1) or other Bordetella species (A37.8). The disease primarily affects the respiratory system, specifically the upper and lower airways, and is characterized by severe, prolonged coughing episodes. It is transmitted via respiratory droplets and is particularly dangerous in infants and young children, though it can affect individuals of any age. The clinical course of whooping cough typi

Are there clinical trials for Whooping cough?

Yes — 11 recruiting clinical trials are currently listed for Whooping cough on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Whooping cough?

25 specialists and care centers treating Whooping cough are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.